secwatch.observer — SEC 8-K summary
======================================

Issuer:     EUDA Health Holdings Ltd (EUDA)
CIK:        0001847846
Form:       8-K
Filed at:   2022-04-12T23:59:59+00:00
Accession:  0001493152-22-009698
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LAX signs $550M SPAC merger with EUDA Health in all-stock deal
--------------------------------------------------------------

- Initial consideration of $550M in LAX shares at $10 per share; up to 9M additional earnout shares at $15, $20, $25 thresholds.
- Closing conditions include LAX shareholders approval, regulatory clearances, minimum $10M EUDA cash, and $5M net tangible assets.
- Seller locked up for 18 months post-close; CEO Meng Dong Tan holds 10% of Seller, a related-party interest.
- Due diligence must be completed by May 31, 2022; deal target close by Nov 24, 2022 unless extended.
- Joint press release issued April 12, 2022; LAX board unanimously approved and recommends shareholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847846/000149315222009698/0001493152-22-009698-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847846/000149315222009698/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-009698

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer